High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas
Authors:
- 22 July 2015
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 467 (3) , 319-327
Abstract
Expression profile analysis of cell cycle biomarkers provides a powerful index of the proliferative state of tumors, which is linked to disease aggressiveness. We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas. The expression of AURKB and GMNN was studied by immunostaining 84 neuroblastomas. A proliferation index (PI) was obtained on scanned immunostained slides using image analysis software. The median PI was 8.5 % for AURKB- and 16.8 % for GMNN-stained slides with a high correlation between the two (r s = 0.72, P < 0.001). The PI for both markers was significantly higher in neuroblastomas from patients with unfavorable clinical (high-risk group, advanced stage, age ≥18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (MYCN amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors. Using Cox regression models, a higher-than-median AURKB and GMNN PI was associated with a significantly shorter overall survival (OS) and event-free survival (EFS) in univariable analysis. In multivariable analysis, a high AURKB PI was associated with significantly shorter OS and EFS, independent of MYCN amplification, and significantly shorter EFS, independent of MKI. High GMNN PI was also associated with significantly shorter OS and EFS after adjusting for MYCN amplification but failed to reach statistical significance after adjusting for MKI. Our study shows that in neuroblastomas, AURKB- or GMNN-based PI provides valuable prognostic information and high PI indicates aggressive disease.Keywords
This publication has 43 references indexed in Scilit:
- Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosisNature Communications, 2013
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectBritish Journal of Cancer, 2012
- Multiparameter analysis using cell cycle biomarkers for small-size lung adenocarcinoma: prognostic implicationsOncology Reports, 2012
- Emerging Role of Geminin as a Prognostic Marker in Systemic MalignanciesJournal of Breast Cancer, 2012
- Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implicationsHistopathology, 2011
- Myc proteins as therapeutic targetsOncogene, 2010
- Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patientsVirchows Archiv, 2009
- Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancerBritish Journal of Cancer, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992European Journal of Cancer, 2000